Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: A review of the last decade

International Journal of Antimicrobial Agents

Volumn 43, Issue 1, 2014, Pages 7-16

  Mackenzie, Michael ^a   Rae, Nikolas ^a   Nathwani, Dilip ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Global; Outcomes; Outpatient parenteral antimicrobial therapy (OPAT); Registry

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; DAPTOMYCIN; ERTAPENEM; FLUCLOXACILLIN; MEROPENEM; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLINASE; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TIMENTIN; VANCOMYCIN;

ANTIMICROBIAL THERAPY; BACTEREMIA; BONE AND JOINT INFECTIONS; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SURVEILLANCE; DRUG SAFETY; ENDOCARDITIS; GASTROINTESTINAL INFECTION; GERIATRIC PATIENT; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MORTALITY; OSTEOARTHROPATHY; OUTCOME ASSESSMENT; OUTPATIENT CARE; OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY; PATIENT SATISFACTION; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RURAL AREA; SKIN INFECTION; SOCIAL STATUS; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION;

GLOBAL; OUTCOMES; OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY (OPAT); REGISTRY;

ADMINISTRATION, INTRAVENOUS; ADULT; AMBULATORY CARE; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; HUMANS; OUTPATIENTS; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84890795161     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.09.006     Document Type: Short Survey

References (70)

1. R.W. Rucker, and G.M. Harrison Outpatient intravenous medications in the management of cystic fibrosis Pediatrics 54 1974 358 360
2. S. Esposito, S. Noviello, S. Leone, A. Tice, G. Seibold, and D. Nathwani International OPAT Registry. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison Int J Antimicrob Agents 24 2004 473 478
3. Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Antimicrobial stewardship: 'Start smart - then focus' Guidance for antimicrobial stewardship in hospitals (England) 2011 Department of Health London, UK https://www.gov.uk/government/uploads/system/uploads/attachment-data/ file/215308/dh-131181.pdf [accessed 08.10.13]
4. A.D. Tice, S.J. Rehm, J.R. Dalovisio, J.S. Bradley, L.P. Martinelli, and D.R. Graham Practice guidelines for outpatient parenteral antimicrobial therapy Clin Infect Dis 38 2004 1651 1672
5. J.A. Paladino, and D. Poretz Outpatient parenteral antimicrobial therapy today Clin Infect Dis 51 Suppl. 2 2010 S198 S208
6. S. Shepperd, H. Doll, R.M. Angus, M.J. Clarke, S. Iliffe, and L. Kalra Hospital at home admission avoidance Cochrane Database Syst Rev 2008 CD007491
7. H.H. Nguyen Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center Clin Infect Dis 51 Suppl. 2 2010 S220 S223
8. S.M. Gordon, N.K. Shrestha, and S.J. Rehm Transitioning antimicrobial stewardship beyond the hospital: the Cleveland Clinic's community-based parenteral anti-infective therapy (CoPAT) program J Hosp Med 6 Suppl. 1 2011 S24 S30
9. M.L. Hoffman-Terry, H.S. Fraimow, T.R. Fox, B.G. Swift, and J.E. Wolf Adverse effects of outpatient parenteral antibiotic therapy Am J Med 106 1999 44 49
10. G.A. Caplan, J.A. Ward, N.J. Brennan, J. Coconis, N. Board, and A. Brown Hospital in the home: a randomised controlled trial Med J Aust 170 1999 156 160
11. P. Corwin, L. Toop, G. McGeoch, M. Than, S. Wynn-Thomas, and J.E. Wells Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital BMJ 330 2005 129
12. J.M. Wolter, R.A. Cagney, and J.G. McCormack A randomised trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases J Infect 48 2004 263 268
13. S. Rehm, M. Campion, D.E. Katz, R. Russo, and H.W. Boucher Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy J Antimicrob Chemother 63 2009 1034 1042
14. R.M. Gesser, K.A. McCarroll, and G.L. Woods Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections J Infect 48 2004 32 38
15. W.J. Martone, K.C. Lindfield, and D.E. Katz Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry Int J Clin Pract 62 2008 1183 1187
16. D. Nathwani, and A. Tice Ambulatory antimicrobial use: the value of an outcomes registry J Antimicrob Chemother 49 2002 149 154
17. British Society for Antimicrobial Chemotherapy e-opat.com 2013 BSAC http://www.e-opat.com/ [accessed 08.08.13]
18. T. Seetoh, D.C.B. Lye, A.R. Cook, S. Archuleta, M. Chan, and Z. Sulaiman An outcomes analysis of outpatient antibiotic therapy (OPAT) in a large Asian cohort Int J Antimicrob Agents 41 2013 569 573
19. A.L.N. Chapman, R.A. Seaton, M.A. Cooper, S. Hedderwick, V. Goodall, and C. Reed Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement J Antimicrob Chemother 67 2012 1053 1062
20. E.G. Muldoon, D.R. Snydman, E.C. Penland, and G.M. Allison Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence Clin Infect Dis 57 2013 419 424
21. D.A. Barr, L. Semple, and R.A. Seaton Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years Int J Antimicrob Agents 39 2012 407 413
22. J. Hitchcock, A.P. Jepson, J. Main, and H.J. Wickens Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series J Antimicrob Chemother 64 2009 630 634
23. A.L.N. Chapman, S. Dixon, D. Andrews, P.J. Lillie, R. Bazaz, and J.D. Patchett Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy: a UK perspective J Antimicrob Chemother 64 2009 1316 1324
24. J. Kieran, A.O. O'Reilly, J. Parker, S. Clarke, and C. Bergin Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting Eur J Clin Microbiol Infect Dis 28 2009 1369 1374
25. Y.M. Yan, M. Singh, K. Tonks, J. Kavi, and N.J. Langford Delivering outpatient antibiotic therapy (OPAT) in an acute medical unit Acute Med 10 2011 22 25
26. A. Upton, R. Ellis-Pegler, and A. Woodhouse Outpatient parenteral antimicrobial therapy (OPAT): a review of experience at Auckland Hospital N Z Med J 117 2004 U1020
27. A.M. Cox, P.N. Malani, S.W. Wiseman, and C.A. Kauffman Home intravenous antimicrobial infusion therapy: a viable option in older adults J Am Geriatr Soc 55 2007 645 650
28. G. Theocharis, P.I. Rafailidis, D. Rodis, I. Kontopidis, S.G. Barbas, and M.E. Falgas Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece Eur J Clin Microbiol Infect Dis 31 2012 2957 2961
29. S. Baharoon, H. Almodaimeg, H. Al Watban, H. Al Jahdali, T. Alenazi, and A. Al Sayyari Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia Ann Saudi Med 31 2011 457 461
30. D. Nathwani, J. Morrison, R.A. Seaton, A.J. France, P. Davey, and K. Gray Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in Tayside Health Bull (Edinb) 57 1999 332 337
31. P.R. Ingram, L. Cerbe, M. Hassell, M. Wilson, and J.R. Dyer Limited role for outpatient antibiotic therapy for community-acquired pneumonia Respirology 13 2008 893 896
32. D.A. Barr, L. Semple, and R.A. Seaton Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study Eur J Clin Microbiol Infect Dis 31 2012 2611 2619
33. P.C. Matthews, C.P. Conlon, A.R. Berendt, J. Kayley, L. Jeffries, and B.L. Atkins Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years J Antimicrob Chemother 60 2007 356 362
34. C. Duncan, D.A. Barr, and R.A. Seaton Outpatient parenteral antimicrobial therapy with ceftriaxone, a review Int J Clin Pharm 34 2012 410 417
35. C. Yong, D.A. Fisher, G.E. Sklar, and S.C. Li A cost analysis of outpatient parenteral antibiotic therapy (OPAT): an Asian perspective Int J Antimicrob Agents 33 2009 46 51
36. G.S. Stein, S.L. Schoolet, D.H. Havlichek, and D.E. Nix Outpatient intravenous antibiotic therapy compared with oral linezolid in patients with skin and soft tissue infections. A pharmacoeconomic analysis Infect Dis Clin Pract 16 2008 235 239
37. Controlled-trials.com. Randomised open label study of oral versus intravenous antibiotic treatment for bone and joint infections requiring prolonged antibiotic treatment: multi-centre study. http://www.controlled- trials.com/ISRCTN91566927 [accessed 12.08.13].
38. A.F. Goodfellow, A.O. Wai, L. Frighetto, C.A. Marrakech, B.M. Ferreira, and M.L. Chase Quality-of-life assessment in an outpatient parenteral antibiotic program Pharmacoeconomics 36 2002 1851 1855
39. C.A. Marra, L. Frighetto, A.F. Goodfellow, A.O. Wai, M.L. Chase, and R.E. Nicol Willingness to pay to assess patient preferences for therapy in a Canadian setting BMC Health Serv Res 5 2005 43
40. A.D. Tice, P.A. Hoaglund, and D.A. Shoultz Risk factors and treatment outcomes in osteomyelitis J Antimicrob Chemother 51 2003 1261 1268
41. C.L. Mackintosh, H.A. White, and R.A. Seaton Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service J Antimicrob Chemother 66 2011 408 415
42. C. Pulcini, T. Couadau, E. Bernard, A. Lorthat-Jacob, T. Bauer, and E. Cua Adverse effects of parenteral antimicrobial therapy for chronic bone infections Eur J Clin Microbiol Infect Dis 27 2008 1227 1232
43. A. Duggal, W. Barsoum, and S.K. Schmitt Patients with prosthetic joint infection on IV antibiotics are at high risk for readmission Clin Orthop Relat Res 467 2009 1727 1731
44. C.M. Licitra, A. Crespo, D. Licitra, and N.C. Wallis-Crespo Daptomycin for the treatment of osteomyelitis and prosthetic joint infection: retrospective analysis of efficacy and safety in an outpatient infusion center Internet J Infect Dis 2011 9
45. H.A. White, J.S. Davis, P. Kittler, and B.J. Currie Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting Intern Med J 41 2011 668 673
46. S. Esposito, S. Leone, S. Noviello, F. Ianniello, M. Fiore, and M. Russo Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study J Chemother 19 2007 417 422
47. R.A. Seaton, E. Sharp, V. Bezlyak, and C.J. Weir Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections Int J Antimicrob Agents 38 2011 243 248
48. T. Garrett, Y. Harbort, M. Trebble, and T. Dochery Once or twice-daily, algorithm-based intravenous cephazolin for home-based cellulitis treatment Emerg Med Australas 24 2012 383 392
49. P.J. Lillie, D. Andrews, K. Eaves, T.C. Darton, and A.L.N. Chapman Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting Eur J Clin Microbiol Infect Dis 29 2010 347 349
50. M. Donald, N. Marlow, E. Swinburn, and M. Wu Emergency department management of home intravenous antibiotic therapy for cellulitis Emerg Med J 22 2005 715 717
51. M.M. Andrews, and C.F. von Reyn Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis Clin Infect Dis 33 2001 203 209
52. C.J. Duncan, D.A. Barr, A. Ho, E. Sharp, L. Semple, and R.A. Seaton Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis J Antimicrob Chemother 68 2013 1650 1654
53. C. Cervera, A. del Río, L. García, M. Sala, M. Almela, and A. Moreno Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study Enferm Infecc Microbiol Clin 29 2011 587 592
54. M.R. Amodeo, T. Clulow, J. Lainchbury, D.R. Murdoch, K. Gallagher, and A. Dyer Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes J Infect 59 2009 387 393
55. J. Larioza, L. Heung, A. Girard, and R.B. Brown Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy South Med J 102 2009 575 579
56. D.G. Partridge, E. O'Brien, and A.L.N. Chapman Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years experience at a UK centre Postgrad Med J 88 2012 377 381
57. J.H. McMahon, J.M. O'Keeffe, Victorian HITH Outcomes Study Group, and M.L. Grayson Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective? Scand J Infect Dis 40 2008 40 43
58. A.K.F. Htin, N.D. Friedman, A. Hughes, D.P. O'Brien, S. Huffam, and A.M. Redden Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis: a retrospective cohort study Intern Med J 43 2013 700 705
59. V.G. Fowler Jr., H.W. Boucher, G.R. Corey, E. Abrutyn, A.W. Karchmer, and M.E. Rupp S. aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus N Engl J Med 355 2006 653 665
60. M. Rodríguez-Cerillo, A. Poza-Montoro, E. Fernandez-Diaz, A. Iñurrieta-Romero, and M. Matesanz-David Home treatment of patients with acute cholecystitis Eur J Intern Med 23 2012 e10 13
61. D.S.G. Chan, S. Archuleta, R.M. Llorin, D.C. Lye, and D. Fisher Standardized outpatient management of Klebsiella pneumoniae liver abscesses Int J Infect Dis 17 2013 e185 e188
62. S. Huffam, S.P. Jacups, P. Kittler, and B.J. Currie Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters Trop Med Int Health 9 2004 715 717
63. M. Montalto The admission of patients with pneumonia directly from the emergency department to hospital in the home Prim Care Resp J 12 2003 12 15
64. R. Bazaz, A.L.N. Chapman, and T.G. Winstanley Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-β-lactamase-producing Gram-negative organisms J Antimicrob Chemother 65 2010 1510 1513
65. B. White, R.A. Seaton, and T.J. Evans Management of Lyme borreliosis: experience from an outpatient parenteral antibiotic therapy service QJM 106 2013 133 138
66. B. White, J.E. Coia, C. Sykes, H. Mather, and R.A. Seaton Enteric fever in returning travellers: role of outpatient parenteral antibiotic therapy J Infect 64 2012 242 245
67. J. Ho, S. Archuleta, Sulaiman, and D. Fisher Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service J Antimicrob Chemother 65 2010 2641 2644
68. J. Ho, S. Archuleta, A. Tice, and D. Fisher International approaches to treating intravenous drug users in outpatient parenteral antibiotic services Infect Dis Clin Pract 20 2012 192 195
69. S. Esposito, S. Leone, S. Noviello, F. Ianniello, M. Russo, and G. Foti Registro Nazionale OPAT. Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study J Chemother 21 2009 193 198
70. J. Pérez-López, A. San José Laporte, J. Pardos-Gea, E. Tapia Melechón, E. Lozano Ortín, and A. Barrio Guirado Safety and efficacy of home intravenous antimicrobial infusion therapy in older patients: a comparative study with younger patients Int J Clin Pract 62 2008 1188 1192